Monosialoganglioside improves Parkinson's disease in rats by inhibiting neuronal apoptosis through ERK1/2 signaling pathway.

Monosialoganglioside improves Parkinson's disease in rats by inhibiting neuronal apoptosis through ERK1/2 signaling pathway. J Neurosurg Sci. 2020 Feb 04;: Authors: Gao F, Han J, Wang Y PMID: 32031358 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32031358?dopt=Abstract

Source: Journal of Neurosurgical Sciences - February 8, 2020 Category: Neurosurgery Tags: J Neurosurg Sci Source Type: research

More News: Brain | Neurology | Neurosurgery | Parkinson's Disease